Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06732102 · ClinicalTrials.gov registry record · NA

Philly CEAL- DECIDE+ Adaptation

A NA study of Cardiovascular Diseases and Social Determinants of Health (SDOH), sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06732102 is a NA study of Cardiovascular Diseases and Social Determinants of Health (SDOH) that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 500 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06732102, a NA study of Cardiovascular Diseases and Social Determinants of Health (SDOH), is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

Cardiovascular disease (CVD) disproportionately affects racial/ethnic minorities and underserved populations in Philadelphia. This study aims to evaluate the effectiveness of an enhanced community health worker (CHW) program that combines the evidence-based DECIDE self-management intervention with structured CHW consultations to improve CVD self-management skills and address social needs. Using a Type 1 Hybrid Effectiveness-Implementation Design, we will recruit 500 Philadelphia residents aged 35-75 with CVD risk factors and unmet social needs. Participants will be offered the DECIDE+ intervention (9 bi-weekly group sessions plus alternating CHW consultations) or continue with standard CHW services. The primary outcome is CVD self-management skills measured by the Self-care of Chronic Illness Inventory Maintenance scale. Secondary outcomes include health behaviors and resolution of social needs. Implementation outcomes will assess CHW experiences, community advisory council impact, and factors influencing participation. Propensity score methods will be used to compare changes in outcomes between DECIDE+ participants and those receiving standard CHW services. Mediation analyses will examine pathways through problem-solving skills, self-efficacy, and social needs resolution. Mixed methods will evaluate implementation outcomes. This study will provide evidence on the effectiveness of integrating an evidence-based self-management program with CHW services to address both clinical and social needs. This study has the potential to generate important and impactful findings that can advance health equity and the science of effective community health worker programs. By rigorously evaluating the real-world implementation of a city-wide CHW-delivered chronic disease self-management program that also addresses collaborative approaches and support to addressing social needs, our findings can provide a roadmap for other communities looking to implement evidence-based interventi

Interventions

  • BEHAVIORAL DECIDE
  • BEHAVIORAL Community Health Worker Support

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-04-14
Est. Completion 2028-03-31
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT06732102

The ClinicalTrials.gov registry entry for NCT06732102 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (98% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which DECIDE is the first listed.

NCT06732102 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06732102 about?

NCT06732102 is a clinical study titled "Philly CEAL- DECIDE+ Adaptation". Cardiovascular disease (CVD) disproportionately affects racial/ethnic minorities and underserved populations in Philadelphia. This study aims to evaluate the effectiveness of an enhanced community health worker (CHW) program that combines the evidence-based DECIDE self-management intervention with s...

What is the current status of trial NCT06732102?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-04-14. Estimated completion is 2028-03-31.

What conditions does trial NCT06732102 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Social Determinants of Health (SDOH), Community Health Workers, Disparities.

What interventions are being tested in trial NCT06732102?

The interventions under investigation include: DECIDE (BEHAVIORAL), Community Health Worker Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06732102?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06732102 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.